⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13540 | 0.79 | — | — | |
| Hydrochloric Acid SCHEMBL8437491 | 0.78 | PNMT (0.43) | — | |
| Hydrochloric Acid SCHEMBL2720370 | 0.78 | PNMT (0.43) | — | |
| Hydrochloric Acid SCHEMBL8435409 | 0.74 | PNMT (0.40) | — | |
| SCHEMBL982394 | 0.67 | HTR2C (0.47) | — | |
| SCHEMBL1868363 | 0.66 | PNMT (0.43) | — | |
| SCHEMBL25592899 | 0.66 | HTR2A (0.64) | — | |
| SCHEMBL6434544 | 0.66 | ALDH1A1 (0.32) | — | |
| Hydrochloric Acid SCHEMBL2999672 | 0.65 | HTR2C (0.46) | — | |
| SCHEMBL18576433 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12559481-B2 | Quinoline derivatives | ELANCO ANIMAL HEALTH GMBH (DE) | 2026-02-24 | — | — | US | disclosed |
| US-12435068-B2 | Anthelmintic compounds | ELANCO ANIMAL HEALTH GMBH (DE) | 2025-10-07 | — | — | US | disclosed |
| US-12391682-B2 | Isoquinoline derivatives and their use for the treatment of parasitic infections | ELANCO ANIMAL HEALTH GMBH (DE) | 2025-08-19 | — | — | US | disclosed |
| US-20250129094-A1 | NEW QUINOLINE DERIVATIVES | ELANCO ANIMAL HEALTH GMBH (DE) | 2025-04-24 | — | — | US | disclosed |
| EP-4003524-B1 | ISOQUINOLINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF PARASITIC INFECTIONS | ELANCO ANIMAL HEALTH GMBH (DE) | 2025-04-09 | — | — | EP | disclosed |
| EP-3634959-B1 | QUINOLINE DERIVATIVES FOR TREATING INFECTIONS WITH HELMINTHS | ELANCO ANIMAL HEALTH GMBH (DE) | 2025-02-26 | — | — | EP | disclosed |
| CN-119409690-A | Novel insect repellent compound | 拜耳动物保健有限责任公司 | 2025-02-11 | — | — | CN | disclosed |
| CN-112074514-B | Quinoline derivatives | 礼蓝动物保健有限公司 | 2024-10-29 | — | — | CN | disclosed |
| WO-2024213752-A1 | LONG-TERM PREVENTION AND/OR TREATMENT OF A DISEASE BY SLO-1 INHIBITORS | ELANCO ANIMAL HEALTH GMBH (DE) | 2024-10-17 | — | — | WO | disclosed |
| EP-3585791-B1 | NEW BICYCLIC PYRAZOLE DERIVATIVES | ELANCO ANIMAL HEALTH GMBH (DE) | 2024-10-16 | — | — | EP | disclosed |
| EP-3643711-A1 | NEW ANTHELMINTIC COMPOUNDS | Bayer Animal Health GmbH (DE) | 2020-04-29 | — | — | EP | disclosed |
| EP-3634959-A1 | QUINOLINE DERIVATIVES FOR TREATING INFECTIONS WITH HELMINTHS | Bayer Animal Health GmbH (DE) | 2020-04-15 | — | — | EP | disclosed |
| EP-3615527-A1 | NEW AZAQUINOLINE DERIVATIVES | Bayer Animal Health GmbH (DE) | 2020-03-04 | — | — | EP | disclosed |
| CN-110770227-A | Novel azaquinoline derivatives | 拜耳动物保健有限责任公司 | 2020-02-07 | — | — | CN | disclosed |
| WO-2019215182-A1 | NEW QUINOLINE DERIVATIVES | BAYER ANIMAL HEALTH GMBH (DE) | 2019-11-14 | — | — | WO | disclosed |
| EP-3538512-A1 | NEW ANTHELMINTIC QUINOLINE-3-CARBOXAMIDE DERIVATIVES | Bayer Animal Health GmbH (DE) | 2019-09-18 | — | — | EP | disclosed |
| WO-2019025341-A1 | QUINOLINE DERIVATIVES FOR TREATING INFECTIONS WITH HELMINTHS | BAYER ANIMAL HEALTH GMBH (DE) | 2019-02-07 | — | — | WO | disclosed |
| WO-2019002132-A1 | NEW AZAQUINOLINE DERIVATIVES | BAYER ANIMAL HEALTH GMBH (DE) | 2019-01-03 | — | — | WO | disclosed |
| WO-2018197401-A1 | NEW BICYCLIC PYRAZOLE DERIVATIVES | BAYER ANIMAL HEALTH GMBH (DE) | 2018-11-01 | — | — | WO | disclosed |
| WO-2018087036-A1 | NEW ANTHELMINTIC QUINOLINE-3-CARBOXAMIDE DERIVATIVES | BAYER ANIMAL HEALTH GMBH (DE) | 2018-05-17 | — | — | WO | disclosed |